Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Update

by · The Cerbat Gem

Dominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) saw a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 4,400 shares, a decline of 10.2% from the September 15th total of 4,900 shares. Based on an average daily trading volume, of 10,300 shares, the short-interest ratio is presently 0.4 days. Approximately 0.1% of the company’s shares are short sold.

Dominari Stock Down 3.1 %

Shares of DOMH stock traded down $0.06 on Thursday, reaching $1.88. 14,990 shares of the stock were exchanged, compared to its average volume of 10,572. The stock has a market cap of $11.16 million, a P/E ratio of -0.41 and a beta of 0.94. The firm has a 50 day moving average of $1.77 and a two-hundred day moving average of $2.04. Dominari has a 1-year low of $1.50 and a 1-year high of $3.20.

Dominari (NASDAQ:DOMH – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.51) EPS for the quarter. The firm had revenue of $6.17 million during the quarter. Dominari had a negative return on equity of 31.02% and a negative net margin of 231.55%.

Dominari Company Profile

(Get Free Report)

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.

Further Reading